Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

Inclusion Criteria: * Outpatient * Documented physician diagnosis of asthma or COPD * Requires use of a controller and long acting beta 2 agonist * Ability to provided written informed consent Exclusion Criteria: * Patients with life threatening asthma or COPD * Historical or current evidence of significant diseases * Immediate or delayed hypersensitivity to inhaled short acting beta2agonist or sympathomimetic drug or any component of the MDI formulation * History of drug or alcohol abuse Abnormal chest x ray not consistent with asthma or COPD * Use of supplemental oxygen; systemic corticosteroids; short acting beta2agonists other than VENTOLIN HFA; antibiotics for respiratory infections; anti-arrhythmics; anticonvulsants; central nervous system stimulants; tricyclic antidepressants and monoamine oxidase inhibitors.